These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16884308)

  • 1. The physicochemical challenges of designing multiple ligands.
    Morphy R; Rankovic Z
    J Med Chem; 2006 Aug; 49(16):4961-70. PubMed ID: 16884308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of target family and functional activity on the physicochemical properties of pre-clinical compounds.
    Morphy R
    J Med Chem; 2006 May; 49(10):2969-78. PubMed ID: 16686538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral delivery of G protein-coupled receptor modulators: an explanation for the observed class difference.
    Beaumont K; Schmid E; Smith DA
    Bioorg Med Chem Lett; 2005 Aug; 15(16):3658-64. PubMed ID: 15982884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status of virtual screening as analysed by target class.
    Stoermer MJ
    Med Chem; 2006 Jan; 2(1):89-112. PubMed ID: 16787359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GLIDA: GPCR-ligand database for chemical genomic drug discovery.
    Okuno Y; Yang J; Taneishi K; Yabuuchi H; Tsujimoto G
    Nucleic Acids Res; 2006 Jan; 34(Database issue):D673-7. PubMed ID: 16381956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-related differences in the physical property profiles of oral drugs.
    Leeson PD; Davis AM
    J Med Chem; 2004 Dec; 47(25):6338-48. PubMed ID: 15566303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virtual exploration of the chemical universe up to 11 atoms of C, N, O, F: assembly of 26.4 million structures (110.9 million stereoisomers) and analysis for new ring systems, stereochemistry, physicochemical properties, compound classes, and drug discovery.
    Fink T; Reymond JL
    J Chem Inf Model; 2007; 47(2):342-53. PubMed ID: 17260980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational Modification of the Biological Profile of GPCR Ligands through Combination with Other Biologically Active Moieties.
    Huang G; Nimczick M; Decker M
    Arch Pharm (Weinheim); 2015 Aug; 348(8):531-40. PubMed ID: 25941009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing active template molecules by combining computational de novo design and human chemist's expertise.
    Lameijer EW; Tromp RA; Spanjersberg RF; Brussee J; Ijzerman AP
    J Med Chem; 2007 Apr; 50(8):1925-32. PubMed ID: 17367122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fragments, network biology and designing multiple ligands.
    Morphy R; Rankovic Z
    Drug Discov Today; 2007 Feb; 12(3-4):156-60. PubMed ID: 17275736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicochemical effects in the representation of molecular structures for drug designing.
    Gasteiger J
    Mini Rev Med Chem; 2003 Dec; 3(8):789-96. PubMed ID: 14529498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of physiochemical property profiles of development and marketed oral drugs.
    Wenlock MC; Austin RP; Barton P; Davis AM; Leeson PD
    J Med Chem; 2003 Mar; 46(7):1250-6. PubMed ID: 12646035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are target-family-privileged substructures truly privileged?
    Schnur DM; Hermsmeier MA; Tebben AJ
    J Med Chem; 2006 Mar; 49(6):2000-9. PubMed ID: 16539387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the relationship between topology and selectivity for druglike molecules.
    Yang Y; Chen H; Nilsson I; Muresan S; Engkvist O
    J Med Chem; 2010 Nov; 53(21):7709-14. PubMed ID: 20942392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel 2D fingerprints for ligand-based virtual screening.
    Ewing T; Baber JC; Feher M
    J Chem Inf Model; 2006; 46(6):2423-31. PubMed ID: 17125184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intramolecular hydrogen bonding in medicinal chemistry.
    Kuhn B; Mohr P; Stahl M
    J Med Chem; 2010 Mar; 53(6):2601-11. PubMed ID: 20175530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role and significance of unconventional hydrogen bonds in small molecule recognition by biological receptors of pharmaceutical relevance.
    Tóth G; Bowers SG; Truong AP; Probst G
    Curr Pharm Des; 2007; 13(34):3476-93. PubMed ID: 18220785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge-based chemoinformatic approaches to drug discovery.
    Ghose AK; Herbertz T; Salvino JM; Mallamo JP
    Drug Discov Today; 2006 Dec; 11(23-24):1107-14. PubMed ID: 17129830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virtual screening of biogenic amine-binding G-protein coupled receptors: comparative evaluation of protein- and ligand-based virtual screening protocols.
    Evers A; Hessler G; Matter H; Klabunde T
    J Med Chem; 2005 Aug; 48(17):5448-65. PubMed ID: 16107144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knowledge-based analysis of multi-potent G-protein coupled receptors ligands.
    Faure P; Dubus E; Ijjaali I; Morlière C; Barberan O; Petitet F
    Eur J Med Chem; 2010 Dec; 45(12):5708-17. PubMed ID: 20933307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.